Visitor Monitoring Drug History: ANCEF
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: ANCEF
FDA Application No: (NDA) 050461
Active Ingredient(s): CEFAZOLIN SODIUM
Company: GLAXOSMITHKLINE
 
Label History
 
View the label approved on June 7, 2004 for ANCEF, (NDA) 050461


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
6/2/2004 139Labeling Revision Letter
Label 
1/6/2005 138Labeling Revision Letter 
1/15/2004 135Labeling Revision Letter
Label 
5/21/2002 134Control Supplement  
7/29/1999 133Labeling Revision  
1/4/1994 132Manufacturing Change or Addition  
7/14/1992 130Labeling Revision  
5/29/1992 129Manufacturing Change or Addition  
9/20/1982 128Labeling Revision  
7/12/1982 127Labeling Revision  
7/12/1982 126Labeling Revision  
6/28/1982 125Labeling Revision  
6/4/1982 124Labeling Revision  
5/18/1982 123Labeling Revision  
5/12/1982 122Labeling Revision  
5/5/1982 121Labeling Revision  
4/20/1982 120Labeling Revision  
3/8/1982 119Labeling Revision  
2/19/1982 118Labeling Revision  
1/4/1982 117Labeling Revision  
11/27/1981 116Control Supplement  
9/3/1981 115Labeling Revision  
9/1/1981 114Labeling Revision  
8/11/1981 113Labeling Revision  
7/23/1981 112Labeling Revision  
6/10/1981 111Labeling Revision  
4/8/1981 110Labeling Revision  
6/19/1981 109Labeling Revision  
3/12/1981 108Labeling Revision  
2/11/1981 107Labeling Revision  
1/27/1981 106Labeling Revision  
7/17/1980 105Labeling Revision  
3/5/1980 104Control Supplement  
2/26/1980 103Labeling Revision  
5/15/1979 101Control Supplement  
2/23/1979 099Expiration Date Change  
11/28/1978 098Control Supplement  
11/14/1978 097Labeling Revision  
10/18/1978 096Labeling Revision  
9/29/1978 095Labeling Revision  
8/28/1978 094Labeling Revision  
8/22/1978 093Labeling Revision  
8/17/1978 092Labeling Revision  
8/10/1978 091Labeling Revision  
7/25/1978 090Labeling Revision  
5/23/1978 089Labeling Revision  
5/23/1978 088Control Supplement  
4/6/1978 087Control Supplement  
12/15/1977 086Labeling Revision  
10/14/1977 085Labeling Revision  
6/9/1977 084Labeling Revision  
5/22/1978 083Labeling Revision  
10/8/1976 082Labeling Revision  
8/12/1976 081Labeling Revision  
8/5/1976 080Labeling Revision  
7/8/1976 079Control Supplement  
6/16/1976 078Labeling Revision  
6/8/1976 077Labeling Revision  
5/10/1976 076Control Supplement  
5/6/1976 075Package Change  
3/15/1976 074Package Change  
3/15/1976 073Package Change  
3/1/1976 072Control Supplement  
2/26/1976 071Labeling Revision  
2/26/1976 070Labeling Revision  
11/20/1975 069Control Supplement  
11/20/1975 068Control Supplement  
9/18/1975 067Control Supplement  
9/10/1975 066Labeling Revision  
6/8/1977 065Labeling Revision  
7/7/1975 064Labeling Revision  
5/12/1975 063Labeling Revision  
4/29/1975 062Labeling Revision  
4/10/1975 061Labeling Revision  
4/10/1975 060Labeling Revision  
2/25/1975 059Labeling Revision  
2/18/1975 058Labeling Revision  
12/24/1974 057Labeling Revision  
9/26/1974 056Labeling Revision  
9/26/1974 055Manufacturing Change or Addition  
6/26/1974 054Control Supplement  
10/3/1974 053Labeling Revision  
3/15/1974 052Control Supplement  
1/23/1974 051Labeling Revision  
6/22/1992 050Control Supplement  
6/28/1991 048Control Supplement  
3/12/1992 045Expiration Date Change  
1/28/1992 044Control Supplement  
2/14/1990 043Control Supplement  
10/4/1973 000Approval  
 
Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test